Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human TRF2 Antibodies:
anti-Mouse (Murine) TRF2 Antibodies:
anti-Rat (Rattus) TRF2 Antibodies:
Go to our pre-filtered search.
Human Monoclonal TRF2 Primary Antibody for IHC, ELISA - ABIN1724941
Diehl, Idowu, Kimmelshue, York, Jackson-Cook, Turner, Holt, Elmore: Elevated TRF2 in advanced breast cancers with short telomeres. in Breast cancer research and treatment 2011
Show all 2 Pubmed References
TERF2 knockdown by RNA interference had no effect on cell proliferation, migration, senescence and apoptosis. Instead, TERF2 knockdown increased the expression of cytokines implicated in inflammation and angiogenesis, except for vascular endothelial growth factor (show VEGF Antibodies).
the telomere stability is under direct control of one of the major pro-oncogenic signaling pathways (RAS/RAF (show RAF1 Antibodies)/MEK (show MAP2K1 Antibodies)/ERK (show EPHB2 Antibodies)) via TRF2 phosphorylation.
the B-domain improves TRF2's interaction with DNA via enhanced long-range electrostatic interactions.
our findings describe TRF2 as a novel SIRT6 (show SIRT6 Antibodies) substrate and demonstrate that acetylation of TRF2 plays a crucial role in the regulation of TRF2 protein stability, thus providing a new route for modulating its expression level during oncogenesis and damage response.
The results suggest that dimerized TRF2 recruits origin recognition complex and stimulates pre-replication complex formation at telomeres through the TRFH domain.
Studied the disruption pattern of of 3D telomere-TRF2 interaction in the progression from mononuclear Hodgkin cells (H) to multinucleated Reed-Sternberg cells (RS).
TRF2, a component of shelterin, binds to core histones to protect chromosome ends from inappropriate DNA damage response and loss of telomeric DNA. The N-terminal Gly/Arg-rich domain (GAR domain) of TRF2 directly binds to the globular domain of core histones.
TRF2 deficiency led to a 1,5-2 fold increase in the radiosensitivity of hMSC-telo1 (show ATM Antibodies) cells through telomere destabilization.
DREEM imaging shows that in contrast to chromatin with DNA wrapping around histones, large TRF2-DNA complexes (with volumes larger than TRF2 tetramers) compact DNA inside TRF2 with portions of folded DNA appearing at the edge of these complexes.
observed that the expression of Sp1 (show PSG1 Antibodies) is down-regulated in the TRF2(DeltaBDeltaM)-induced senescence, which was mediated by ATM (show ATM Antibodies) and p38 MAPK (show MAPK14 Antibodies)
Selective inactivation of Terf2 in neural progenitors induced apoptosis, resulting in a complete loss of the brain structure.
The authors propose that TRF2 masks and stabilizes the t-loop three-way junction, thereby protecting telomeres from detrimental deletions and PARP1 (show PARP1 Antibodies) activation.
Overexpressing TRF2-S and silencing FMRP (show FMR1 Antibodies) promotes mRNA entry to axons and enhances axonal outgrowth and neurotransmitter release from presynaptic terminals.
TRF2 binds and transactivates the promoter of the angiogenic tyrosine kinase (show TYRO3 Antibodies) platelet-derived growth factor receptor beta (show PDGFRB Antibodies) (PDGFRbeta).
role of TRF2 in skin homeostasis, is reported.
shelterin protein TIN2 (show TINF2 Antibodies) can protect chromosome ends as a TRF2-tethered TIN2 (show TINF2 Antibodies)/TPP1 (show TPP1 Antibodies)/POT1 (show POT1 Antibodies) complex that lacks a physical connection to TRF1 (show TERF1 Antibodies)
We concluded that genomic instability resulting from loss of TRF2 expression provides biological advantages to the cancer stem cell population
Conditional deletion of individual components of shelterin showed that TRF2 was required for the formation and/or maintenance of t-loops, whereas deletion of TRF1 (show TERF1 Antibodies), Rap1 (show TERF2IP Antibodies), or the POT1 (show POT1 Antibodies) proteins (POT1a (show POT1 Antibodies) and POT1b) had no effect on the frequency of t-loop occurrence.
TAF7L (show TAF7L Antibodies) associates with TRF2 both in vitro and in testis, suggesting that TAF7L (show TAF7L Antibodies) likely cooperates directly with TRF2 at promoters of a subset of postmeiotic genes to regulate spermiogenesis.
This gene encodes a telomere specific protein, TERF2, which is a component of the telomere nucleoprotein complex. This protein is present at telomeres in metaphase of the cell cycle, is a second negative regulator of telomere length and plays a key role in the protective activity of telomeres. While having similar telomere binding activity and domain organization, TERF2 differs from TERF1 in that its N terminus is basic rather than acidic.
telomeric repeat binding factor 2
, TTAGGG repeat-binding factor 2
, telomeric DNA-binding protein
, telomeric repeat binding protein 2
, telomeric repeat-binding factor 2
, TTAGGG-repeat binding factor 2 TRF2
, telomeric repeat binding factor a
, TTAGGG repeat binding factor 2